Remigromig
Based on 1 Customer Validation
Remigromig (EYE-103; MK-3000) is a humanized dual-target monoclonal antibody that targets LRP5 and FZD4. Remigromig activates the Wnt/β-catenin signaling pathway by mimicking the natural ligand Norrin, induces tight junction formation and restores blood-retinal barrier function. Administered via intravitreal injection, Remigromig reduces retinal vascular leakage, and demonstrates improvements in best-corrected visual acuity and reductions in retinal thickness in studies of diabetic macular edema. Remigromig can be used for research related to macular degeneration.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 95.25%
- CAS. Nr.: 3059389-31-7
- Molecular Weight:199.68 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Target
LRP5 & FZD4
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Frizzled-4/CD344 Protein, Human (HEK293, HY-P74140) can bind Remigromig. The ED50 for this effect is 17.22 ng/mL. -
Immobilized LRP-5 Protein, Human (HEK293, HY-P77989) can bind Remigromig. The ED50 for this effect is 891.6 ng/mL.
Product Details
-
CAS. Nr. 3059389-31-7
-
Accession O75197 & Q9ULV1
-
Synonyms EYE-103; MK-3000
-
Molecular Weight 199.68 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
immunoglobulin [(diabody VH1-Vk2-G1(h-CH2-CH3)-VH-G1(CH1-h)_Lkappa)]_[( diabody VH2-Vk1-G1(h-CH2-CH3)-VH-G1(CH1-h)_L-kappa)]
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reinheit
95.25%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Versand
Shipping with dry ice.
Reinheit & Dokumentation
-
Data Sheet (272 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Remigromig
- 3059389-31-7
- EYE-103
- MK-3000
- EYE103
- EYE 103
- MK3000
- MK 3000
- MK-3000
- Wnt
- Wnt/β-catenin signaling
- Dutch Belted rabbits
- tight junction proteins
- blood-retina barrier
- oxygen-induced retinopathy mice
- diabetic retinopathy
- FZD4
- bEnd.3 mouse brain microvascular endothelial cells
- LRP5
- blood-brain barrier
- Inhibitor
- inhibitor
- inhibit